Client News
Four Therapeutic Vaccines Show Efficacy
NEWS: Four Therapeutic Vaccines Show Efficacy; Other Leading Therapeutic HIV Vaccines, Anti-Immune Hyperactivation, and Immune-Based Therapies Hit Milestones
NutriPharma ASA and Subsidiary Bionor Immuno AS Change Name to Bionor Pharma ASA
NEWS: NutriPharma ASA and Subsidiary Bionor Immuno AS Change Name to Bionor Pharma ASA.
Report on Phase II Clinical Study of Marshall Edwards’ Phenoxodiol
Report on Phase II Clinical Study of Marshall Edwards’ Phenoxodiol in Prostate Cancer to Be Presented at ASCO.
Nutri Pharma ASA Adds New CFO to Commercialize Bionor Immuno Pipeline
Mr. Rolf Henning Lem has been appointed new CFO of Nutri Pharma ASA.
Marshall Edwards Appoints New President and CEO
Daniel Gold, Ph.D., an accomplished executive in drug development and translational research, has been appointed President and Chief Executive Officer of the Company.

Recent Comments